Global Plaque Psoriasis Treatment Medications Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Plaque Psoriasis Treatment Medications market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Plaque psoriasis is the most common form of psoriasis, a chronic, relapsing autoimmune skin disease characterized by red, thick patches of skin with silvery white scales.
This report is a detailed and comprehensive analysis for global Plaque Psoriasis Treatment Medications market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Plaque Psoriasis Treatment Medications market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plaque Psoriasis Treatment Medications market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plaque Psoriasis Treatment Medications market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plaque Psoriasis Treatment Medications market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Plaque Psoriasis Treatment Medications
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Plaque Psoriasis Treatment Medications market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Plaque Psoriasis Treatment Medications market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plaque Psoriasis Treatment Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plaque Psoriasis Treatment Medications, with price, sales quantity, revenue, and global market share of Plaque Psoriasis Treatment Medications from 2021 to 2026.
Chapter 3, the Plaque Psoriasis Treatment Medications competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plaque Psoriasis Treatment Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Plaque Psoriasis Treatment Medications market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plaque Psoriasis Treatment Medications.
Chapter 14 and 15, to describe Plaque Psoriasis Treatment Medications sales channel, distributors, customers, research findings and conclusion.
Plaque psoriasis is the most common form of psoriasis, a chronic, relapsing autoimmune skin disease characterized by red, thick patches of skin with silvery white scales.
This report is a detailed and comprehensive analysis for global Plaque Psoriasis Treatment Medications market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Plaque Psoriasis Treatment Medications market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plaque Psoriasis Treatment Medications market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plaque Psoriasis Treatment Medications market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plaque Psoriasis Treatment Medications market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Plaque Psoriasis Treatment Medications
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Plaque Psoriasis Treatment Medications market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Plaque Psoriasis Treatment Medications market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Biologics
- Small Molecule Drugs
- Non-biologic Drugs
- Hospital
- Clinic
- Other
- Amgen
- Allergan
- Dermira
- Eli Lilly
- Novartis
- Merck
- Johnson & Johnson
- Pfizer
- AstraZeneca
- AbbVie
- LEO Pharma
- Biogen
- Galectin Therapeutics
- Cellceutix
- Bayer
- Organon
- UCB
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plaque Psoriasis Treatment Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plaque Psoriasis Treatment Medications, with price, sales quantity, revenue, and global market share of Plaque Psoriasis Treatment Medications from 2021 to 2026.
Chapter 3, the Plaque Psoriasis Treatment Medications competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plaque Psoriasis Treatment Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Plaque Psoriasis Treatment Medications market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plaque Psoriasis Treatment Medications.
Chapter 14 and 15, to describe Plaque Psoriasis Treatment Medications sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Plaque Psoriasis Treatment Medications Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Biologics
1.3.3 Small Molecule Drugs
1.3.4 Non-biologic Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Plaque Psoriasis Treatment Medications Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Plaque Psoriasis Treatment Medications Market Size & Forecast
1.5.1 Global Plaque Psoriasis Treatment Medications Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Plaque Psoriasis Treatment Medications Sales Quantity (2021-2032)
1.5.3 Global Plaque Psoriasis Treatment Medications Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Plaque Psoriasis Treatment Medications Product and Services
2.1.4 Amgen Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Amgen Recent Developments/Updates
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Plaque Psoriasis Treatment Medications Product and Services
2.2.4 Allergan Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Allergan Recent Developments/Updates
2.3 Dermira
2.3.1 Dermira Details
2.3.2 Dermira Major Business
2.3.3 Dermira Plaque Psoriasis Treatment Medications Product and Services
2.3.4 Dermira Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Dermira Recent Developments/Updates
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Plaque Psoriasis Treatment Medications Product and Services
2.4.4 Eli Lilly Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Eli Lilly Recent Developments/Updates
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Plaque Psoriasis Treatment Medications Product and Services
2.5.4 Novartis Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Novartis Recent Developments/Updates
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Plaque Psoriasis Treatment Medications Product and Services
2.6.4 Merck Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Merck Recent Developments/Updates
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Plaque Psoriasis Treatment Medications Product and Services
2.7.4 Johnson & Johnson Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Johnson & Johnson Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Plaque Psoriasis Treatment Medications Product and Services
2.8.4 Pfizer Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Pfizer Recent Developments/Updates
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Plaque Psoriasis Treatment Medications Product and Services
2.9.4 AstraZeneca Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 AstraZeneca Recent Developments/Updates
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business
2.10.3 AbbVie Plaque Psoriasis Treatment Medications Product and Services
2.10.4 AbbVie Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 AbbVie Recent Developments/Updates
2.11 LEO Pharma
2.11.1 LEO Pharma Details
2.11.2 LEO Pharma Major Business
2.11.3 LEO Pharma Plaque Psoriasis Treatment Medications Product and Services
2.11.4 LEO Pharma Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 LEO Pharma Recent Developments/Updates
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Plaque Psoriasis Treatment Medications Product and Services
2.12.4 Biogen Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Biogen Recent Developments/Updates
2.13 Galectin Therapeutics
2.13.1 Galectin Therapeutics Details
2.13.2 Galectin Therapeutics Major Business
2.13.3 Galectin Therapeutics Plaque Psoriasis Treatment Medications Product and Services
2.13.4 Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Galectin Therapeutics Recent Developments/Updates
2.14 Cellceutix
2.14.1 Cellceutix Details
2.14.2 Cellceutix Major Business
2.14.3 Cellceutix Plaque Psoriasis Treatment Medications Product and Services
2.14.4 Cellceutix Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Cellceutix Recent Developments/Updates
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Plaque Psoriasis Treatment Medications Product and Services
2.15.4 Bayer Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Bayer Recent Developments/Updates
2.16 Organon
2.16.1 Organon Details
2.16.2 Organon Major Business
2.16.3 Organon Plaque Psoriasis Treatment Medications Product and Services
2.16.4 Organon Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Organon Recent Developments/Updates
2.17 UCB
2.17.1 UCB Details
2.17.2 UCB Major Business
2.17.3 UCB Plaque Psoriasis Treatment Medications Product and Services
2.17.4 UCB Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 UCB Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PLAQUE PSORIASIS TREATMENT MEDICATIONS BY MANUFACTURER
3.1 Global Plaque Psoriasis Treatment Medications Sales Quantity by Manufacturer (2021-2026)
3.2 Global Plaque Psoriasis Treatment Medications Revenue by Manufacturer (2021-2026)
3.3 Global Plaque Psoriasis Treatment Medications Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Plaque Psoriasis Treatment Medications by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Plaque Psoriasis Treatment Medications Manufacturer Market Share in 2025
3.4.3 Top 6 Plaque Psoriasis Treatment Medications Manufacturer Market Share in 2025
3.5 Plaque Psoriasis Treatment Medications Market: Overall Company Footprint Analysis
3.5.1 Plaque Psoriasis Treatment Medications Market: Region Footprint
3.5.2 Plaque Psoriasis Treatment Medications Market: Company Product Type Footprint
3.5.3 Plaque Psoriasis Treatment Medications Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Plaque Psoriasis Treatment Medications Market Size by Region
4.1.1 Global Plaque Psoriasis Treatment Medications Sales Quantity by Region (2021-2032)
4.1.2 Global Plaque Psoriasis Treatment Medications Consumption Value by Region (2021-2032)
4.1.3 Global Plaque Psoriasis Treatment Medications Average Price by Region (2021-2032)
4.2 North America Plaque Psoriasis Treatment Medications Consumption Value (2021-2032)
4.3 Europe Plaque Psoriasis Treatment Medications Consumption Value (2021-2032)
4.4 Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value (2021-2032)
4.5 South America Plaque Psoriasis Treatment Medications Consumption Value (2021-2032)
4.6 Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
5.2 Global Plaque Psoriasis Treatment Medications Consumption Value by Type (2021-2032)
5.3 Global Plaque Psoriasis Treatment Medications Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
6.2 Global Plaque Psoriasis Treatment Medications Consumption Value by Application (2021-2032)
6.3 Global Plaque Psoriasis Treatment Medications Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
7.2 North America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
7.3 North America Plaque Psoriasis Treatment Medications Market Size by Country
7.3.1 North America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2032)
7.3.2 North America Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
8.2 Europe Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
8.3 Europe Plaque Psoriasis Treatment Medications Market Size by Country
8.3.1 Europe Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2032)
8.3.2 Europe Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Plaque Psoriasis Treatment Medications Market Size by Region
9.3.1 Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
10.2 South America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
10.3 South America Plaque Psoriasis Treatment Medications Market Size by Country
10.3.1 South America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2032)
10.3.2 South America Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Plaque Psoriasis Treatment Medications Market Size by Country
11.3.1 Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Plaque Psoriasis Treatment Medications Market Drivers
12.2 Plaque Psoriasis Treatment Medications Market Restraints
12.3 Plaque Psoriasis Treatment Medications Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Plaque Psoriasis Treatment Medications and Key Manufacturers
13.2 Manufacturing Costs Percentage of Plaque Psoriasis Treatment Medications
13.3 Plaque Psoriasis Treatment Medications Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Plaque Psoriasis Treatment Medications Typical Distributors
14.3 Plaque Psoriasis Treatment Medications Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Plaque Psoriasis Treatment Medications Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Biologics
1.3.3 Small Molecule Drugs
1.3.4 Non-biologic Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Plaque Psoriasis Treatment Medications Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Plaque Psoriasis Treatment Medications Market Size & Forecast
1.5.1 Global Plaque Psoriasis Treatment Medications Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Plaque Psoriasis Treatment Medications Sales Quantity (2021-2032)
1.5.3 Global Plaque Psoriasis Treatment Medications Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Plaque Psoriasis Treatment Medications Product and Services
2.1.4 Amgen Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Amgen Recent Developments/Updates
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Plaque Psoriasis Treatment Medications Product and Services
2.2.4 Allergan Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Allergan Recent Developments/Updates
2.3 Dermira
2.3.1 Dermira Details
2.3.2 Dermira Major Business
2.3.3 Dermira Plaque Psoriasis Treatment Medications Product and Services
2.3.4 Dermira Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Dermira Recent Developments/Updates
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Plaque Psoriasis Treatment Medications Product and Services
2.4.4 Eli Lilly Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Eli Lilly Recent Developments/Updates
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Plaque Psoriasis Treatment Medications Product and Services
2.5.4 Novartis Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Novartis Recent Developments/Updates
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Plaque Psoriasis Treatment Medications Product and Services
2.6.4 Merck Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Merck Recent Developments/Updates
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Plaque Psoriasis Treatment Medications Product and Services
2.7.4 Johnson & Johnson Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Johnson & Johnson Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Plaque Psoriasis Treatment Medications Product and Services
2.8.4 Pfizer Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Pfizer Recent Developments/Updates
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Plaque Psoriasis Treatment Medications Product and Services
2.9.4 AstraZeneca Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 AstraZeneca Recent Developments/Updates
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business
2.10.3 AbbVie Plaque Psoriasis Treatment Medications Product and Services
2.10.4 AbbVie Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 AbbVie Recent Developments/Updates
2.11 LEO Pharma
2.11.1 LEO Pharma Details
2.11.2 LEO Pharma Major Business
2.11.3 LEO Pharma Plaque Psoriasis Treatment Medications Product and Services
2.11.4 LEO Pharma Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 LEO Pharma Recent Developments/Updates
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Plaque Psoriasis Treatment Medications Product and Services
2.12.4 Biogen Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Biogen Recent Developments/Updates
2.13 Galectin Therapeutics
2.13.1 Galectin Therapeutics Details
2.13.2 Galectin Therapeutics Major Business
2.13.3 Galectin Therapeutics Plaque Psoriasis Treatment Medications Product and Services
2.13.4 Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Galectin Therapeutics Recent Developments/Updates
2.14 Cellceutix
2.14.1 Cellceutix Details
2.14.2 Cellceutix Major Business
2.14.3 Cellceutix Plaque Psoriasis Treatment Medications Product and Services
2.14.4 Cellceutix Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Cellceutix Recent Developments/Updates
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Plaque Psoriasis Treatment Medications Product and Services
2.15.4 Bayer Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Bayer Recent Developments/Updates
2.16 Organon
2.16.1 Organon Details
2.16.2 Organon Major Business
2.16.3 Organon Plaque Psoriasis Treatment Medications Product and Services
2.16.4 Organon Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Organon Recent Developments/Updates
2.17 UCB
2.17.1 UCB Details
2.17.2 UCB Major Business
2.17.3 UCB Plaque Psoriasis Treatment Medications Product and Services
2.17.4 UCB Plaque Psoriasis Treatment Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 UCB Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PLAQUE PSORIASIS TREATMENT MEDICATIONS BY MANUFACTURER
3.1 Global Plaque Psoriasis Treatment Medications Sales Quantity by Manufacturer (2021-2026)
3.2 Global Plaque Psoriasis Treatment Medications Revenue by Manufacturer (2021-2026)
3.3 Global Plaque Psoriasis Treatment Medications Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Plaque Psoriasis Treatment Medications by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Plaque Psoriasis Treatment Medications Manufacturer Market Share in 2025
3.4.3 Top 6 Plaque Psoriasis Treatment Medications Manufacturer Market Share in 2025
3.5 Plaque Psoriasis Treatment Medications Market: Overall Company Footprint Analysis
3.5.1 Plaque Psoriasis Treatment Medications Market: Region Footprint
3.5.2 Plaque Psoriasis Treatment Medications Market: Company Product Type Footprint
3.5.3 Plaque Psoriasis Treatment Medications Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Plaque Psoriasis Treatment Medications Market Size by Region
4.1.1 Global Plaque Psoriasis Treatment Medications Sales Quantity by Region (2021-2032)
4.1.2 Global Plaque Psoriasis Treatment Medications Consumption Value by Region (2021-2032)
4.1.3 Global Plaque Psoriasis Treatment Medications Average Price by Region (2021-2032)
4.2 North America Plaque Psoriasis Treatment Medications Consumption Value (2021-2032)
4.3 Europe Plaque Psoriasis Treatment Medications Consumption Value (2021-2032)
4.4 Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value (2021-2032)
4.5 South America Plaque Psoriasis Treatment Medications Consumption Value (2021-2032)
4.6 Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
5.2 Global Plaque Psoriasis Treatment Medications Consumption Value by Type (2021-2032)
5.3 Global Plaque Psoriasis Treatment Medications Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
6.2 Global Plaque Psoriasis Treatment Medications Consumption Value by Application (2021-2032)
6.3 Global Plaque Psoriasis Treatment Medications Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
7.2 North America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
7.3 North America Plaque Psoriasis Treatment Medications Market Size by Country
7.3.1 North America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2032)
7.3.2 North America Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
8.2 Europe Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
8.3 Europe Plaque Psoriasis Treatment Medications Market Size by Country
8.3.1 Europe Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2032)
8.3.2 Europe Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Plaque Psoriasis Treatment Medications Market Size by Region
9.3.1 Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
10.2 South America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
10.3 South America Plaque Psoriasis Treatment Medications Market Size by Country
10.3.1 South America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2032)
10.3.2 South America Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Plaque Psoriasis Treatment Medications Market Size by Country
11.3.1 Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Plaque Psoriasis Treatment Medications Market Drivers
12.2 Plaque Psoriasis Treatment Medications Market Restraints
12.3 Plaque Psoriasis Treatment Medications Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Plaque Psoriasis Treatment Medications and Key Manufacturers
13.2 Manufacturing Costs Percentage of Plaque Psoriasis Treatment Medications
13.3 Plaque Psoriasis Treatment Medications Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Plaque Psoriasis Treatment Medications Typical Distributors
14.3 Plaque Psoriasis Treatment Medications Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Plaque Psoriasis Treatment Medications Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Plaque Psoriasis Treatment Medications Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Plaque Psoriasis Treatment Medications Product and Services
Table 6. Amgen Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Amgen Recent Developments/Updates
Table 8. Allergan Basic Information, Manufacturing Base and Competitors
Table 9. Allergan Major Business
Table 10. Allergan Plaque Psoriasis Treatment Medications Product and Services
Table 11. Allergan Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Allergan Recent Developments/Updates
Table 13. Dermira Basic Information, Manufacturing Base and Competitors
Table 14. Dermira Major Business
Table 15. Dermira Plaque Psoriasis Treatment Medications Product and Services
Table 16. Dermira Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Dermira Recent Developments/Updates
Table 18. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly Major Business
Table 20. Eli Lilly Plaque Psoriasis Treatment Medications Product and Services
Table 21. Eli Lilly Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Eli Lilly Recent Developments/Updates
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Plaque Psoriasis Treatment Medications Product and Services
Table 26. Novartis Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Novartis Recent Developments/Updates
Table 28. Merck Basic Information, Manufacturing Base and Competitors
Table 29. Merck Major Business
Table 30. Merck Plaque Psoriasis Treatment Medications Product and Services
Table 31. Merck Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Merck Recent Developments/Updates
Table 33. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 34. Johnson & Johnson Major Business
Table 35. Johnson & Johnson Plaque Psoriasis Treatment Medications Product and Services
Table 36. Johnson & Johnson Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Johnson & Johnson Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Plaque Psoriasis Treatment Medications Product and Services
Table 41. Pfizer Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Pfizer Recent Developments/Updates
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Plaque Psoriasis Treatment Medications Product and Services
Table 46. AstraZeneca Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. AstraZeneca Recent Developments/Updates
Table 48. AbbVie Basic Information, Manufacturing Base and Competitors
Table 49. AbbVie Major Business
Table 50. AbbVie Plaque Psoriasis Treatment Medications Product and Services
Table 51. AbbVie Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. AbbVie Recent Developments/Updates
Table 53. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 54. LEO Pharma Major Business
Table 55. LEO Pharma Plaque Psoriasis Treatment Medications Product and Services
Table 56. LEO Pharma Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. LEO Pharma Recent Developments/Updates
Table 58. Biogen Basic Information, Manufacturing Base and Competitors
Table 59. Biogen Major Business
Table 60. Biogen Plaque Psoriasis Treatment Medications Product and Services
Table 61. Biogen Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Biogen Recent Developments/Updates
Table 63. Galectin Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Galectin Therapeutics Major Business
Table 65. Galectin Therapeutics Plaque Psoriasis Treatment Medications Product and Services
Table 66. Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Galectin Therapeutics Recent Developments/Updates
Table 68. Cellceutix Basic Information, Manufacturing Base and Competitors
Table 69. Cellceutix Major Business
Table 70. Cellceutix Plaque Psoriasis Treatment Medications Product and Services
Table 71. Cellceutix Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Cellceutix Recent Developments/Updates
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Plaque Psoriasis Treatment Medications Product and Services
Table 76. Bayer Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Bayer Recent Developments/Updates
Table 78. Organon Basic Information, Manufacturing Base and Competitors
Table 79. Organon Major Business
Table 80. Organon Plaque Psoriasis Treatment Medications Product and Services
Table 81. Organon Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Organon Recent Developments/Updates
Table 83. UCB Basic Information, Manufacturing Base and Competitors
Table 84. UCB Major Business
Table 85. UCB Plaque Psoriasis Treatment Medications Product and Services
Table 86. UCB Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. UCB Recent Developments/Updates
Table 88. Global Plaque Psoriasis Treatment Medications Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 89. Global Plaque Psoriasis Treatment Medications Revenue by Manufacturer (2021-2026) & (USD Million)
Table 90. Global Plaque Psoriasis Treatment Medications Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 91. Market Position of Manufacturers in Plaque Psoriasis Treatment Medications, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 92. Head Office and Plaque Psoriasis Treatment Medications Production Site of Key Manufacturer
Table 93. Plaque Psoriasis Treatment Medications Market: Company Product Type Footprint
Table 94. Plaque Psoriasis Treatment Medications Market: Company Product Application Footprint
Table 95. Plaque Psoriasis Treatment Medications New Market Entrants and Barriers to Market Entry
Table 96. Plaque Psoriasis Treatment Medications Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Plaque Psoriasis Treatment Medications Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 98. Global Plaque Psoriasis Treatment Medications Sales Quantity by Region (2021-2026) & (K Units)
Table 99. Global Plaque Psoriasis Treatment Medications Sales Quantity by Region (2027-2032) & (K Units)
Table 100. Global Plaque Psoriasis Treatment Medications Consumption Value by Region (2021-2026) & (USD Million)
Table 101. Global Plaque Psoriasis Treatment Medications Consumption Value by Region (2027-2032) & (USD Million)
Table 102. Global Plaque Psoriasis Treatment Medications Average Price by Region (2021-2026) & (US$/Unit)
Table 103. Global Plaque Psoriasis Treatment Medications Average Price by Region (2027-2032) & (US$/Unit)
Table 104. Global Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 105. Global Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 106. Global Plaque Psoriasis Treatment Medications Consumption Value by Type (2021-2026) & (USD Million)
Table 107. Global Plaque Psoriasis Treatment Medications Consumption Value by Type (2027-2032) & (USD Million)
Table 108. Global Plaque Psoriasis Treatment Medications Average Price by Type (2021-2026) & (US$/Unit)
Table 109. Global Plaque Psoriasis Treatment Medications Average Price by Type (2027-2032) & (US$/Unit)
Table 110. Global Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 111. Global Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 112. Global Plaque Psoriasis Treatment Medications Consumption Value by Application (2021-2026) & (USD Million)
Table 113. Global Plaque Psoriasis Treatment Medications Consumption Value by Application (2027-2032) & (USD Million)
Table 114. Global Plaque Psoriasis Treatment Medications Average Price by Application (2021-2026) & (US$/Unit)
Table 115. Global Plaque Psoriasis Treatment Medications Average Price by Application (2027-2032) & (US$/Unit)
Table 116. North America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 117. North America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 118. North America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 119. North America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 120. North America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2026) & (K Units)
Table 121. North America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2027-2032) & (K Units)
Table 122. North America Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2026) & (USD Million)
Table 123. North America Plaque Psoriasis Treatment Medications Consumption Value by Country (2027-2032) & (USD Million)
Table 124. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 125. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 126. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 127. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 128. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2026) & (K Units)
Table 129. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Country (2027-2032) & (K Units)
Table 130. Europe Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2026) & (USD Million)
Table 131. Europe Plaque Psoriasis Treatment Medications Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 133. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 134. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 135. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 136. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Region (2021-2026) & (K Units)
Table 137. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Region (2027-2032) & (K Units)
Table 138. Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value by Region (2021-2026) & (USD Million)
Table 139. Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value by Region (2027-2032) & (USD Million)
Table 140. South America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 141. South America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 142. South America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 143. South America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 144. South America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2026) & (K Units)
Table 145. South America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2027-2032) & (K Units)
Table 146. South America Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2026) & (USD Million)
Table 147. South America Plaque Psoriasis Treatment Medications Consumption Value by Country (2027-2032) & (USD Million)
Table 148. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 149. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 150. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 151. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 152. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2026) & (K Units)
Table 153. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Country (2027-2032) & (K Units)
Table 154. Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2026) & (USD Million)
Table 155. Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value by Country (2027-2032) & (USD Million)
Table 156. Plaque Psoriasis Treatment Medications Raw Material
Table 157. Key Manufacturers of Plaque Psoriasis Treatment Medications Raw Materials
Table 158. Plaque Psoriasis Treatment Medications Typical Distributors
Table 159. Plaque Psoriasis Treatment Medications Typical Customers
Table 1. Global Plaque Psoriasis Treatment Medications Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Plaque Psoriasis Treatment Medications Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Plaque Psoriasis Treatment Medications Product and Services
Table 6. Amgen Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Amgen Recent Developments/Updates
Table 8. Allergan Basic Information, Manufacturing Base and Competitors
Table 9. Allergan Major Business
Table 10. Allergan Plaque Psoriasis Treatment Medications Product and Services
Table 11. Allergan Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Allergan Recent Developments/Updates
Table 13. Dermira Basic Information, Manufacturing Base and Competitors
Table 14. Dermira Major Business
Table 15. Dermira Plaque Psoriasis Treatment Medications Product and Services
Table 16. Dermira Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Dermira Recent Developments/Updates
Table 18. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly Major Business
Table 20. Eli Lilly Plaque Psoriasis Treatment Medications Product and Services
Table 21. Eli Lilly Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Eli Lilly Recent Developments/Updates
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Plaque Psoriasis Treatment Medications Product and Services
Table 26. Novartis Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Novartis Recent Developments/Updates
Table 28. Merck Basic Information, Manufacturing Base and Competitors
Table 29. Merck Major Business
Table 30. Merck Plaque Psoriasis Treatment Medications Product and Services
Table 31. Merck Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Merck Recent Developments/Updates
Table 33. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 34. Johnson & Johnson Major Business
Table 35. Johnson & Johnson Plaque Psoriasis Treatment Medications Product and Services
Table 36. Johnson & Johnson Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Johnson & Johnson Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Plaque Psoriasis Treatment Medications Product and Services
Table 41. Pfizer Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Pfizer Recent Developments/Updates
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Plaque Psoriasis Treatment Medications Product and Services
Table 46. AstraZeneca Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. AstraZeneca Recent Developments/Updates
Table 48. AbbVie Basic Information, Manufacturing Base and Competitors
Table 49. AbbVie Major Business
Table 50. AbbVie Plaque Psoriasis Treatment Medications Product and Services
Table 51. AbbVie Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. AbbVie Recent Developments/Updates
Table 53. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 54. LEO Pharma Major Business
Table 55. LEO Pharma Plaque Psoriasis Treatment Medications Product and Services
Table 56. LEO Pharma Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. LEO Pharma Recent Developments/Updates
Table 58. Biogen Basic Information, Manufacturing Base and Competitors
Table 59. Biogen Major Business
Table 60. Biogen Plaque Psoriasis Treatment Medications Product and Services
Table 61. Biogen Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Biogen Recent Developments/Updates
Table 63. Galectin Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Galectin Therapeutics Major Business
Table 65. Galectin Therapeutics Plaque Psoriasis Treatment Medications Product and Services
Table 66. Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Galectin Therapeutics Recent Developments/Updates
Table 68. Cellceutix Basic Information, Manufacturing Base and Competitors
Table 69. Cellceutix Major Business
Table 70. Cellceutix Plaque Psoriasis Treatment Medications Product and Services
Table 71. Cellceutix Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Cellceutix Recent Developments/Updates
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Plaque Psoriasis Treatment Medications Product and Services
Table 76. Bayer Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Bayer Recent Developments/Updates
Table 78. Organon Basic Information, Manufacturing Base and Competitors
Table 79. Organon Major Business
Table 80. Organon Plaque Psoriasis Treatment Medications Product and Services
Table 81. Organon Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Organon Recent Developments/Updates
Table 83. UCB Basic Information, Manufacturing Base and Competitors
Table 84. UCB Major Business
Table 85. UCB Plaque Psoriasis Treatment Medications Product and Services
Table 86. UCB Plaque Psoriasis Treatment Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. UCB Recent Developments/Updates
Table 88. Global Plaque Psoriasis Treatment Medications Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 89. Global Plaque Psoriasis Treatment Medications Revenue by Manufacturer (2021-2026) & (USD Million)
Table 90. Global Plaque Psoriasis Treatment Medications Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 91. Market Position of Manufacturers in Plaque Psoriasis Treatment Medications, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 92. Head Office and Plaque Psoriasis Treatment Medications Production Site of Key Manufacturer
Table 93. Plaque Psoriasis Treatment Medications Market: Company Product Type Footprint
Table 94. Plaque Psoriasis Treatment Medications Market: Company Product Application Footprint
Table 95. Plaque Psoriasis Treatment Medications New Market Entrants and Barriers to Market Entry
Table 96. Plaque Psoriasis Treatment Medications Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Plaque Psoriasis Treatment Medications Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 98. Global Plaque Psoriasis Treatment Medications Sales Quantity by Region (2021-2026) & (K Units)
Table 99. Global Plaque Psoriasis Treatment Medications Sales Quantity by Region (2027-2032) & (K Units)
Table 100. Global Plaque Psoriasis Treatment Medications Consumption Value by Region (2021-2026) & (USD Million)
Table 101. Global Plaque Psoriasis Treatment Medications Consumption Value by Region (2027-2032) & (USD Million)
Table 102. Global Plaque Psoriasis Treatment Medications Average Price by Region (2021-2026) & (US$/Unit)
Table 103. Global Plaque Psoriasis Treatment Medications Average Price by Region (2027-2032) & (US$/Unit)
Table 104. Global Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 105. Global Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 106. Global Plaque Psoriasis Treatment Medications Consumption Value by Type (2021-2026) & (USD Million)
Table 107. Global Plaque Psoriasis Treatment Medications Consumption Value by Type (2027-2032) & (USD Million)
Table 108. Global Plaque Psoriasis Treatment Medications Average Price by Type (2021-2026) & (US$/Unit)
Table 109. Global Plaque Psoriasis Treatment Medications Average Price by Type (2027-2032) & (US$/Unit)
Table 110. Global Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 111. Global Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 112. Global Plaque Psoriasis Treatment Medications Consumption Value by Application (2021-2026) & (USD Million)
Table 113. Global Plaque Psoriasis Treatment Medications Consumption Value by Application (2027-2032) & (USD Million)
Table 114. Global Plaque Psoriasis Treatment Medications Average Price by Application (2021-2026) & (US$/Unit)
Table 115. Global Plaque Psoriasis Treatment Medications Average Price by Application (2027-2032) & (US$/Unit)
Table 116. North America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 117. North America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 118. North America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 119. North America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 120. North America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2026) & (K Units)
Table 121. North America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2027-2032) & (K Units)
Table 122. North America Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2026) & (USD Million)
Table 123. North America Plaque Psoriasis Treatment Medications Consumption Value by Country (2027-2032) & (USD Million)
Table 124. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 125. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 126. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 127. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 128. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2026) & (K Units)
Table 129. Europe Plaque Psoriasis Treatment Medications Sales Quantity by Country (2027-2032) & (K Units)
Table 130. Europe Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2026) & (USD Million)
Table 131. Europe Plaque Psoriasis Treatment Medications Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 133. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 134. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 135. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 136. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Region (2021-2026) & (K Units)
Table 137. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity by Region (2027-2032) & (K Units)
Table 138. Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value by Region (2021-2026) & (USD Million)
Table 139. Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value by Region (2027-2032) & (USD Million)
Table 140. South America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 141. South America Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 142. South America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 143. South America Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 144. South America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2026) & (K Units)
Table 145. South America Plaque Psoriasis Treatment Medications Sales Quantity by Country (2027-2032) & (K Units)
Table 146. South America Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2026) & (USD Million)
Table 147. South America Plaque Psoriasis Treatment Medications Consumption Value by Country (2027-2032) & (USD Million)
Table 148. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Type (2021-2026) & (K Units)
Table 149. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Type (2027-2032) & (K Units)
Table 150. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Application (2021-2026) & (K Units)
Table 151. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Application (2027-2032) & (K Units)
Table 152. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Country (2021-2026) & (K Units)
Table 153. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity by Country (2027-2032) & (K Units)
Table 154. Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value by Country (2021-2026) & (USD Million)
Table 155. Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value by Country (2027-2032) & (USD Million)
Table 156. Plaque Psoriasis Treatment Medications Raw Material
Table 157. Key Manufacturers of Plaque Psoriasis Treatment Medications Raw Materials
Table 158. Plaque Psoriasis Treatment Medications Typical Distributors
Table 159. Plaque Psoriasis Treatment Medications Typical Customers
LIST OF FIGURES
Figure 1. Plaque Psoriasis Treatment Medications Picture
Figure 2. Global Plaque Psoriasis Treatment Medications Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type in 2025
Figure 4. Biologics Examples
Figure 5. Small Molecule Drugs Examples
Figure 6. Non-biologic Drugs Examples
Figure 7. Global Plaque Psoriasis Treatment Medications Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application in 2025
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Other Examples
Figure 12. Global Plaque Psoriasis Treatment Medications Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 13. Global Plaque Psoriasis Treatment Medications Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 14. Global Plaque Psoriasis Treatment Medications Sales Quantity (2021-2032) & (K Units)
Figure 15. Global Plaque Psoriasis Treatment Medications Price (2021-2032) & (US$/Unit)
Figure 16. Global Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Manufacturer in 2025
Figure 17. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Manufacturer in 2025
Figure 18. Producer Shipments of Plaque Psoriasis Treatment Medications by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 19. Top 3 Plaque Psoriasis Treatment Medications Manufacturer (Revenue) Market Share in 2025
Figure 20. Top 6 Plaque Psoriasis Treatment Medications Manufacturer (Revenue) Market Share in 2025
Figure 21. Global Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Region (2021-2032)
Figure 22. Global Plaque Psoriasis Treatment Medications Consumption Value Market Share by Region (2021-2032)
Figure 23. North America Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 24. Europe Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 25. Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 26. South America Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 27. Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 28. Global Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 29. Global Plaque Psoriasis Treatment Medications Consumption Value Market Share by Type (2021-2032)
Figure 30. Global Plaque Psoriasis Treatment Medications Average Price by Type (2021-2032) & (US$/Unit)
Figure 31. Global Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 32. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021-2032)
Figure 33. Global Plaque Psoriasis Treatment Medications Average Price by Application (2021-2032) & (US$/Unit)
Figure 34. North America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 35. North America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 36. North America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Country (2021-2032)
Figure 37. North America Plaque Psoriasis Treatment Medications Consumption Value Market Share by Country (2021-2032)
Figure 38. United States Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 39. Canada Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 40. Mexico Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 42. Europe Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 43. Europe Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Country (2021-2032)
Figure 44. Europe Plaque Psoriasis Treatment Medications Consumption Value Market Share by Country (2021-2032)
Figure 45. Germany Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 46. France Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 47. United Kingdom Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 48. Russia Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 49. Italy Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 50. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 51. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 52. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Region (2021-2032)
Figure 53. Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value Market Share by Region (2021-2032)
Figure 54. China Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 55. Japan Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 56. South Korea Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 57. India Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 58. Southeast Asia Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 59. Australia Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 60. South America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 61. South America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 62. South America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Country (2021-2032)
Figure 63. South America Plaque Psoriasis Treatment Medications Consumption Value Market Share by Country (2021-2032)
Figure 64. Brazil Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 65. Argentina Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 66. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 67. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 68. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Country (2021-2032)
Figure 69. Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value Market Share by Country (2021-2032)
Figure 70. Turkey Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 71. Egypt Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 72. Saudi Arabia Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 73. South Africa Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 74. Plaque Psoriasis Treatment Medications Market Drivers
Figure 75. Plaque Psoriasis Treatment Medications Market Restraints
Figure 76. Plaque Psoriasis Treatment Medications Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Plaque Psoriasis Treatment Medications in 2025
Figure 79. Manufacturing Process Analysis of Plaque Psoriasis Treatment Medications
Figure 80. Plaque Psoriasis Treatment Medications Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Plaque Psoriasis Treatment Medications Picture
Figure 2. Global Plaque Psoriasis Treatment Medications Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type in 2025
Figure 4. Biologics Examples
Figure 5. Small Molecule Drugs Examples
Figure 6. Non-biologic Drugs Examples
Figure 7. Global Plaque Psoriasis Treatment Medications Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application in 2025
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Other Examples
Figure 12. Global Plaque Psoriasis Treatment Medications Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 13. Global Plaque Psoriasis Treatment Medications Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 14. Global Plaque Psoriasis Treatment Medications Sales Quantity (2021-2032) & (K Units)
Figure 15. Global Plaque Psoriasis Treatment Medications Price (2021-2032) & (US$/Unit)
Figure 16. Global Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Manufacturer in 2025
Figure 17. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Manufacturer in 2025
Figure 18. Producer Shipments of Plaque Psoriasis Treatment Medications by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 19. Top 3 Plaque Psoriasis Treatment Medications Manufacturer (Revenue) Market Share in 2025
Figure 20. Top 6 Plaque Psoriasis Treatment Medications Manufacturer (Revenue) Market Share in 2025
Figure 21. Global Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Region (2021-2032)
Figure 22. Global Plaque Psoriasis Treatment Medications Consumption Value Market Share by Region (2021-2032)
Figure 23. North America Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 24. Europe Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 25. Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 26. South America Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 27. Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 28. Global Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 29. Global Plaque Psoriasis Treatment Medications Consumption Value Market Share by Type (2021-2032)
Figure 30. Global Plaque Psoriasis Treatment Medications Average Price by Type (2021-2032) & (US$/Unit)
Figure 31. Global Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 32. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021-2032)
Figure 33. Global Plaque Psoriasis Treatment Medications Average Price by Application (2021-2032) & (US$/Unit)
Figure 34. North America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 35. North America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 36. North America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Country (2021-2032)
Figure 37. North America Plaque Psoriasis Treatment Medications Consumption Value Market Share by Country (2021-2032)
Figure 38. United States Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 39. Canada Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 40. Mexico Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 42. Europe Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 43. Europe Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Country (2021-2032)
Figure 44. Europe Plaque Psoriasis Treatment Medications Consumption Value Market Share by Country (2021-2032)
Figure 45. Germany Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 46. France Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 47. United Kingdom Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 48. Russia Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 49. Italy Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 50. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 51. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 52. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Region (2021-2032)
Figure 53. Asia-Pacific Plaque Psoriasis Treatment Medications Consumption Value Market Share by Region (2021-2032)
Figure 54. China Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 55. Japan Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 56. South Korea Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 57. India Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 58. Southeast Asia Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 59. Australia Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 60. South America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 61. South America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 62. South America Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Country (2021-2032)
Figure 63. South America Plaque Psoriasis Treatment Medications Consumption Value Market Share by Country (2021-2032)
Figure 64. Brazil Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 65. Argentina Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 66. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Type (2021-2032)
Figure 67. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Application (2021-2032)
Figure 68. Middle East & Africa Plaque Psoriasis Treatment Medications Sales Quantity Market Share by Country (2021-2032)
Figure 69. Middle East & Africa Plaque Psoriasis Treatment Medications Consumption Value Market Share by Country (2021-2032)
Figure 70. Turkey Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 71. Egypt Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 72. Saudi Arabia Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 73. South Africa Plaque Psoriasis Treatment Medications Consumption Value (2021-2032) & (USD Million)
Figure 74. Plaque Psoriasis Treatment Medications Market Drivers
Figure 75. Plaque Psoriasis Treatment Medications Market Restraints
Figure 76. Plaque Psoriasis Treatment Medications Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Plaque Psoriasis Treatment Medications in 2025
Figure 79. Manufacturing Process Analysis of Plaque Psoriasis Treatment Medications
Figure 80. Plaque Psoriasis Treatment Medications Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
